Literature DB >> 11118922

Ultrasound-guided percutaneous ethanol injection under general anesthesia for the treatment of hepatocellular carcinoma on cirrhosis: long-term results in 268 patients.

A Giorgio1, L Tarantino, G de Stefano, A Perrotta, V Aloisio, L del Viscovo, A Alaia, G Lettieri.   

Abstract

OBJECTIVE: Percutaneous ethanol injection (PEI) under general anesthesia (One-shot PEI) is a therapy for large and multiple hepatocellular carcinoma (HCC) by the injection of a large amount of ethanol into the tumor. We report our results with 5-year survival rates in patients with HCC on cirrhosis treated with One-shot PEI. PATIENTS AND METHODS: From October 1992 to March 1998, 268 cirrhotic patients (age 42-82 years; 191 males; 95 Child-Pugh's A class, 150 B and 23 C class of cirrhosis) with 515 HCC nodules underwent One-shot PEI. Diameter of HCC nodules ranged from 0.6 to 14 cm (mean 5.02 +/- 2.2 cm; median: 4 cm). One hundred and thirty-eight patients had a single nodule (range 3.2-14 cm; mean 5.6 +/- 2.1 cm), 130 had multiple nodules, up to six nodules (mean 2.9 nodules) (range 0.6-11 cm; mean 4.8 +/- 2.1 cm)
RESULTS: CT showed complete necrosis in 357/506 nodules (70%). Five patients (1.8%) with nine nodules died as a result of the procedure (variceal bleeding in three cases, liver failure in one and hemoperitoneum in one). The overall survival rates were 93, 83, 74, 65 and 59% at 1, 2, 3, 4 and 5 years, respectively. Survival rates were 90, 84, 82 and 82% at 12, 24, 36 and 48 months, respectively, in patients with a single nodule less than or = 5 cm, and 97, 71, 59, 59 and 59% at 12, 24, 36, 48 and 60 months, respectively, in patients with single nodule >5 cm. Patients with multiple nodules had survival rates of 97, 89, 75, 60 and 60% at 12, 24, 36, 48 and 60 months, respectively.
CONCLUSION: PEI of large and multiple HCC showed survivals similar to conventional PEI for patients with smaller tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118922     DOI: 10.1016/s0929-8266(00)00113-0

Source DB:  PubMed          Journal:  Eur J Ultrasound        ISSN: 0929-8266


  10 in total

1.  Ultrasound-guided percutaneous irreversible electroporation of hepatic and abdominal tumors not eligible for surgery or thermal ablation: a western report on safety and efficacy.

Authors:  A Giorgio; F Amendola; A Calvanese; E Ingenito; B Santoro; P Gatti; E Ciracì; P Matteucci; V Giorgio
Journal:  J Ultrasound       Date:  2019-03-06

2.  Combination of repeated single-session percutaneous ethanol injection and transarterial chemoembolisation compared to repeated single-session percutaneous ethanol injection in patients with non-resectable hepatocellular carcinoma.

Authors:  Arne Dettmer; Timm-D Kirchhoff; Michael Gebel; Lars Zender; Nisar-P Malek; Bernhard Panning; Ajay Chavan; Herbert Rosenthal; Stefan Kubicka; Susanne Krusche; Sonja Merkesdal; Michael Galanski; Michael-P Manns; Joerg-S Bleck
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

3.  Percutaneous ethanol ablation of hepatocellular carcinoma: periprocedural onset alcohol toxicity and pancreatitis following conventional percutaneous ethanol ablation treatment.

Authors:  Kirsteen Rennie Burton; Helena O'Dwyer; Charles Scudamore
Journal:  Can J Gastroenterol       Date:  2009-08       Impact factor: 3.522

Review 4.  Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review.

Authors:  Luis Calzadilla Bertot; Masaya Sato; Ryosuke Tateishi; Haruhiko Yoshida; Kazuhiko Koike
Journal:  Eur Radiol       Date:  2011-08-20       Impact factor: 5.315

Review 5.  Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; Flora Hau-Fung Tsang; John Wong
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

6.  Hepatocellular carcinoma: current treatment strategies.

Authors:  Aaron Shields; K Rajender Reddy
Journal:  Curr Treat Options Gastroenterol       Date:  2005-12

7.  Experimental and clinical assessment of percutaneous hepatic quantified ethanol injection in treatment of hepatic carcinoma.

Authors:  Li-Wu Lin; Xue-Ying Lin; Yi-Mi He; Shang-Da Gao; En-Sheng Xue; Xiao-Dong Lin; Li-Yun Yu
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

8.  The effects of percutaneous ethanol injection followed by 20-kHz ultrasound and microbubbles on rabbit hepatic tumors.

Authors:  Zhi Yong Shen; Gan Lin Xia; Ming Feng Wu; Lei Yan Ji; Yong Jun Li
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-26       Impact factor: 4.553

9.  Radiofrequency ablation of hepatocellular carcinoma extended into the portal vein: Preliminary results.

Authors:  A Giorgio; G de Stefano; A Di Sarno; N Farella; V Giorgio; U Scognamiglio; A Mariniello; G Liorre; A Perrotta; N Mariniello
Journal:  J Ultrasound       Date:  2009-01-20

10.  Microwave Ablation in Intermediate Hepatocellular Carcinoma in Cirrhosis: An Italian Multicenter Prospective Study.

Authors:  Antonio Giorgio; Pietro Gatti; Luca Montesarchio; Maria Gabriella Merola; Ferdinando Amendola; Andrea Calvanese; Gaetano Iaquinto; Massimiliano Fontana; Emanuela Ciracì; Stefano Semeraro; Bruno Santoro; Carmine Coppola; Paolo Matteucci; Valentina Giorgio
Journal:  J Clin Transl Hepatol       Date:  2018-07-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.